Sonoma PharmaceuticalsSNOA 
$0.16-27.27%24h
-27.27%24h
Global rank36032
Market cap$543.04K
Change 7d-30.43%
YTD Performance-11.11%
SP500 benchmarkUnderperform
P/E-0.11
P/S0.04
Revenue$13.27M
Earnings-$5.15M
Dividend yield-
Sonoma Pharmaceuticals (SNOA) Total Liabilities
SNOA Total Liabilities in 2022: $8.25M
According to Sonoma Pharmaceuticals latest financial reports the total liabilities of SNOA is $8.25M, an decrease of -18.66% to 2022. At the end of 2022 company had $10.15M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Sonoma Pharmaceuticals is responsible for during its operational activities.
Sonoma Pharmaceuticals (SNOA) Total Liabilities History from 2023 to 2022
-
Value:-
SNOA Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $8.25M | -18.66% |
| 2022 | $10.15M | 5.44% |
| 2021 | $9.62M | 7.69% |
| 2020 | $8.94M | 325.17% |
| 2019 | $2.10M | - |
View the Top Total Liabilies Stocks
